Asia-Pacific (APAC) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Asia-Pacific pharmaceuticals market had total revenues of $424.4 billion in 2022, representing a compound annual growth rate (CAGR) of 9.1% between 2017 and 2022.
- 0
- The Asia-Pacific region acquired a 32.7% share of the global pharmaceuticals market in 2022. The growth in the pharmaceuticals market is mainly due to the growth in emerging markets such as China and India. Emerging markets bring new opportunities to pharmaceutical companies.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Asia-Pacific pharmaceuticals market by value in 2022?
- What will be the size of the Asia-Pacific pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in Asia-Pacific's pharmaceuticals market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the most recent market developments?
- 8 Company Profiles
- 8.1. Yangtze River Pharmaceutical Group
- 8.2. Shanghai Pharmaceuticals Holding Co Ltd
- 8.3. Daiichi Sankyo Co Ltd
- 8.4. Takeda Pharmaceutical Company Limited
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Asia-Pacific pharmaceuticals market value: $ billion, 2017-22
- Table 2: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2022
- Table 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2022-27
- Table 4: Yangtze River Pharmaceutical Group: key facts
- Table 5: Yangtze River Pharmaceutical Group: Key Employees
- Table 6: Shanghai Pharmaceuticals Holding Co Ltd: key facts
- Table 7: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
- Table 8: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
- Table 9: Daiichi Sankyo Co Ltd: key facts
- Table 10: Daiichi Sankyo Co Ltd: Annual Financial Ratios
- Table 11: Daiichi Sankyo Co Ltd: Key Employees
- Table 12: Daiichi Sankyo Co Ltd: Key Employees Continued
- Table 13: Takeda Pharmaceutical Company Limited: key facts
- Table 14: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
- Table 15: Takeda Pharmaceutical Company Limited: Key Employees
- Table 16: Takeda Pharmaceutical Company Limited: Key Employees Continued
- Table 17: Asia-Pacific exchange rate, 2018-22
- List of Figures
- Figure 1: Asia-Pacific pharmaceuticals market value: $ billion, 2017-22
- Figure 2: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2022
- Figure 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2022-27
- Figure 4: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2022
- Figure 5: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2022
- Figure 6: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2022
- Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2022
- Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2022
- Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook